Sorcero, the AI-powered intelligence platform for life sciences, announced $42.5 million in Series B financing led by NewSpring Growth, NewSpring Capital's dedicated growth equity strategy that invests in fast-growing, industry-transforming technology companies. They are joined by Leawood Venture Capital and Blu Ventures, bringing the company's total capital raised to $59 million. The latest funding allows Sorcero to accelerate expansion across medical affairs, safety, scientific communications, and medical device segments globally, continue scaling its platform for a medical-insights driven engagement model, and meet life sciences' critical need to drive adoption of breakthrough therapies.